89 related articles for article (PubMed ID: 18838483)
1. Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone.
Bolego C; Buccellati C; Prada A; Gaion RM; Folco G; Sala A
FASEB J; 2009 Feb; 23(2):605-12. PubMed ID: 18838483
[TBL] [Abstract][Full Text] [Related]
2. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells.
Hermenegildo C; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A
J Pharmacol Exp Ther; 2005 Nov; 315(2):722-8. PubMed ID: 16046614
[TBL] [Abstract][Full Text] [Related]
3. Progestogens stimulate prostacyclin production by human endothelial cells.
Hermenegildo C; Oviedo PJ; García-Martínez MC; García-Pérez MA; Tarín JJ; Cano A
Hum Reprod; 2005 Jun; 20(6):1554-61. PubMed ID: 15734756
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and -2.
Oviedo PJ; Hermenegildo C; Tarín JJ; Cano A
Fertil Steril; 2005 Jun; 83(6):1822-9. PubMed ID: 15950656
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress.
Toniolo A; Buccellati C; Pinna C; Gaion RM; Sala A; Bolego C
PLoS One; 2013; 8(2):e56683. PubMed ID: 23441213
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
10. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}.
Sobrino A; Oviedo PJ; Novella S; Laguna-Fernandez A; Bueno C; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
J Mol Endocrinol; 2010 Apr; 44(4):237-46. PubMed ID: 20110403
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin production in tryptase and thrombin stimulated human bladder endothelial cells: effect of pretreatment with phospholipase A2 and cyclooxygenase inhibitors.
Portell C; Rickard A; Vinson S; McHowat J
J Urol; 2006 Oct; 176(4 Pt 1):1661-5. PubMed ID: 16952710
[TBL] [Abstract][Full Text] [Related]
12. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2.
Oviedo PJ; Hermenegildo C; Cano A
Menopause; 2004; 11(4):430-7. PubMed ID: 15243281
[TBL] [Abstract][Full Text] [Related]
14. High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells.
Zhou Q; Zhou Y; Kummerow FA
Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):1-7. PubMed ID: 19135546
[TBL] [Abstract][Full Text] [Related]
15. eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetics.
Bolego C; Buccellati C; Radaelli T; Cetin I; Puglisi L; Folco G; Sala A
Biochem Biophys Res Commun; 2006 Jan; 339(1):188-90. PubMed ID: 16297879
[TBL] [Abstract][Full Text] [Related]
16. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
Di Francesco L; Totani L; Dovizio M; Piccoli A; Di Francesco A; Salvatore T; Pandolfi A; Evangelista V; Dercho RA; Seta F; Patrignani P
Circ Res; 2009 Feb; 104(4):506-13. PubMed ID: 19122175
[TBL] [Abstract][Full Text] [Related]
17. Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events.
Mitchell JA; Lucas R; Vojnovic I; Hasan K; Pepper JR; Warner TD
FASEB J; 2006 Dec; 20(14):2468-75. PubMed ID: 17142796
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers.
Weber AA; Heim HK; Schumacher M; Schrör K; Hohlfeld T
Platelets; 2007 Aug; 18(5):379-85. PubMed ID: 17654308
[TBL] [Abstract][Full Text] [Related]
19. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
Churchman A; Baydoun AR; Hoffman R
Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
